Sentinel Node and Endometrial Cancer

NCT00987051CompletedNAINTERVENTIONAL

Summary

Key Facts

Lead Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

133

Start Date

2007-04-01

Completion Date

2009-12-01

Study Type

INTERVENTIONAL

Official Title

Validation of the Sentinel Node in Endometrial Cancer

Interventions

Detection of sentinel node

Conditions

Endometrial Neoplasms

Eligibility

Age Range

18 Years+

Sex

FEMALE

Inclusion Criteria:

* patient over 18 years old with a surgery planned for endometrial cancer
* endometrial cancer proved by biopsy
* early stage of endometrial cancer (FIGO stage 1-2)
* without contraindication to surgery
* inform consent signed
* affiliated to general health system

Exclusion Criteria:

* endometrial cancer FIGO stages 3-4
* previous history of surgery modifying lymphatic drainage (conization myomectomy)
* pregnant women or breast feeding

Outcome Measures

Primary Outcomes

Detection and false negative rates of sentinel node

Time frame: During the surgery (hysterectomy)

Secondary Outcomes

Morbidity and recurrence rates

Time frame: During 24 months

Locations

Tenon Hospital, Paris, France

Sentinel Node and Endometrial Cancer